+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Care Devices Market - Global Forecast to 2030- Product Image
Diabetes Care Devices Market - Global Forecast to 2030- Product Image
Sale

Diabetes Care Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311206
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Diabetes Care Devices Market grew from USD 3.10 billion in 2024 to USD 3.68 billion in 2025. It is expected to continue growing at a CAGR of 18.64%, reaching USD 8.66 billion by 2030.

The global prevalence of diabetes continues to rise, presenting both challenges and opportunities for stakeholders across healthcare ecosystems. Advancements in diabetes care devices have revolutionized the management of this chronic disease, enabling real-time monitoring and precise insulin delivery. As patients and providers demand greater accuracy, ease of use, and integration with digital platforms, manufacturers are compelled to innovate across product design, connectivity, and data analytics. This executive summary delves into the major market forces shaping the diabetes care devices arena, examining regulatory dynamics, technological breakthroughs, and evolving patient expectations. It establishes the foundation for understanding how segmentation by device type and end user informs strategic decision-making. Built on the latest industry research, this overview synthesizes insights from tariff developments, regional trends, and the competitive landscape. Readers will gain a clear, concise view of the opportunities and risks inherent in the diabetes care space, setting the stage for actionable guidance. Whether you are a medical device executive, investor, or policy architect, these insights will equip you to navigate a complex market with confidence and clarity.

Transformative Shifts Reshaping Diabetes Care Solutions

The diabetes care market is experiencing transformative shifts driven by the convergence of biotechnology and digital health. Connected continuous glucose monitoring systems are transitioning from standalone sensors to ecosystem platforms that integrate with smartphones and cloud-based analytics. Artificial intelligence-powered algorithms now deliver predictive alerts, enabling proactive interventions that reduce hypoglycemia events. On the insulin delivery front, patch pumps and smart pens are enabling seamless dose tracking and remote titration. Integration with telemedicine bolsters patient adherence and allows care teams to tailor regimens more precisely. Moreover, consumer wearables equipped with noninvasive glucose sensing remain in development, signaling a future where routine finger-stick testing could become obsolete. Regulatory agencies are adapting pathways to accelerate approval of interoperable devices, fostering an ecosystem where data fluidity and security coexist. Combined, these trends underscore a patient-centric paradigm in which insights gleaned from real-world data drive continuous improvement across product portfolios. As digital therapeutics and closed-loop systems gain traction, the diabetes care device landscape is poised for unprecedented transformation.

Impact of United States Tariffs in 2025 on Diabetes Device Supply Chains

In 2025, newly enacted tariffs within the United States impose additional duties on critical components and finished diabetes care devices, influencing cost structures across the supply chain. Manufacturers face increased expenses for imported sensors, transmitters, and pump parts, prompting strategic realignments in sourcing and production. Several industry players are exploring nearshoring options to mitigate tariff pass-through and maintain competitive pricing, while others are absorbing marginal cost increases to preserve market share. Payers are closely monitoring device pricing trends, with some adjusting reimbursement frameworks to account for tariff-driven inflation. These shifts underscore the importance of supply chain resilience, as disruptions in component availability could delay time to market for key product launches. Simultaneously, the tariff landscape incentivizes onshore research and development initiatives, leading to expanded domestic manufacturing investments. Proactive collaboration among manufacturers, suppliers, and distributors is critical to navigating this evolving trade environment. Ultimately, the 2025 tariff changes will serve as a catalyst for greater supply chain diversification and strategic partnerships.

Key Segmentation Insights Across Devices and End Users

Segmentation by device type reveals two primary categories: blood glucose monitoring devices and insulin delivery devices. Within monitoring, continuous glucose monitoring systems distinguish themselves through real-time data streams, supported by receivers, sensors, and transmitters designed for extended wear. Self-monitoring blood glucose devices remain indispensable, encompassing meters, lancets, and test strips that offer cost-effective solutions for frequent testing. On the insulin delivery side, pens-both disposable and reusable-cater to convenience and dose accuracy, while pumps, including patch and traditional models, deliver precise, programmable therapies. Insulin syringes continue to serve niche applications where affordability is paramount. Meanwhile, segmentation by end user highlights diverse adoption patterns: diagnostic centers leverage high-throughput analyzers for population screening; home care settings drive demand for user-friendly wearable devices; hospitals and clinics prioritize integrated systems that support acute management protocols; and research and academic laboratories push innovation boundaries through clinical studies. By analyzing performance across these axes, stakeholders can identify high-growth niches, optimize product portfolios, and align marketing strategies with the distinct needs of each customer segment.

Regional Dynamics and Growth Trajectories

Regional analysis reveals distinct dynamics across the three major markets. The Americas maintain leadership in technology adoption, buoyed by established reimbursement pathways and a robust innovation infrastructure. High patient awareness fuels growth in advanced continuous monitoring and smart insulin delivery solutions. In Europe, regulatory harmonization under the Medical Device Regulation framework streamlines approvals, yet market fragmentation across member states demands tailored market entry strategies. The Middle East and Africa are emerging as growth frontiers, driven by expanding healthcare investments and public-private partnerships aimed at improving chronic disease management. Across Asia-Pacific, rapid urbanization, rising disposable incomes, and government initiatives to expand universal health coverage are accelerating demand for cost-effective monitoring and delivery devices. Local manufacturers in regions such as China and India are scaling production, intensifying competition and driving price sensitivity. These regional insights inform channel strategies, pricing models, and clinical evidence generation plans, enabling manufacturers to localize their approaches effectively.

Competitive Landscape and Leading Industry Players

The competitive landscape is anchored by organizations that combine global reach with technological depth. Abbott Laboratories continues to pioneer continuous glucose monitoring platforms with sensor accuracy and interoperability enhancements. DexCom, Inc. expands its footprint through algorithmic improvements and integration partnerships. F. Hoffmann-La Roche AG and Becton, Dickinson and Company collaborate on next-generation self-monitoring solutions, while Johnson & Johnson Services, Inc. leverages pen injection innovations to enhance dosing convenience. Medtronic PLC advances closed-loop insulin delivery through enriched data platforms. Novo Nordisk A/S and Sanofi S.A. drive pen device adoption via connectivity features that integrate with dose-tracking apps. Eli Lilly and Company develops smart pen ecosystems aligned with telehealth initiatives. B. Braun SE and Nova Biomedical, Inc. focus on infusion systems and point-of-care analyzers, respectively, catering to hospital networks. Acon Laboratories, Inc., AgaMatrix, Inc., and Bionime Corporation address emerging market needs with cost-competitive monitoring products. Arkray, Inc. specializes in meter precision, reinforcing its presence in diagnostic centers.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize a multifaceted strategy to capitalize on evolving market conditions. First, invest in end-to-end connectivity by embedding secure data transmission and AI-powered insights, thereby delivering value beyond device hardware. Second, diversify supply chains by incorporating dual-source agreements and onshore manufacturing to cushion against future trade policy shifts. Third, deepen payer engagement through robust health economics evidence that demonstrates cost savings and improved patient outcomes, facilitating favorable reimbursement. Fourth, forge alliances with technology providers, research institutions, and patient advocacy groups to drive co-development and bolster clinical validation efforts. Fifth, tailor go-to-market strategies by region, aligning pricing models with local healthcare funding mechanisms and competitive dynamics. Sixth, accelerate digital therapeutics integration, enabling combination offerings that merge devices with behavior-change programs. Finally, foster a culture of continuous innovation by allocating resources to early-stage sensor research and miniaturization, ensuring a sustainable pipeline of next-generation solutions.

Conclusion: Navigating the Future of Diabetes Care

As diabetes care devices converge with digital health, stakeholders must navigate complex intersections of technology, regulation, and patient engagement. The growing emphasis on connected ecosystems presents opportunities for device manufacturers to reposition themselves as data-driven service providers. Simultaneously, evolving tariff regimes and regional market intricacies necessitate agile supply chain and market entry strategies. By aligning innovation pipelines with payer and patient needs, organizations can capture value in both advanced and cost-sensitive segments. Collaboration across industry, academia, and regulatory bodies will accelerate the adoption of closed-loop systems and noninvasive monitoring modalities. Ultimately, companies that embrace end-to-end offerings-combining hardware, software, and services-will emerge as leaders in this transformative era of diabetes management. A clear, patient-centric roadmap will be key to sustaining growth, enhancing outcomes, and driving long-term differentiation.

Market Segmentation & Coverage

This research report categorizes the Diabetes Care Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Blood Glucose Monitoring Devices
    • Continuous Glucose Monitoring (CGM) Devices
      • Receiver
      • Sensors
      • Transmitters
    • Self-Monitoring Of Blood Glucose (SMBG) Devices
      • Blood Glucose Meters
      • Lancets
      • Test Strips
  • Insulin Delivery Devices
    • Insulin Pens
      • Disposable Insulin Pens
      • Reusable Insulin Pens
    • Insulin Pumps
      • Patch Pumps
      • Traditional Insulin Pumps
    • Insulin Syringes
  • Diagnostic Centers
  • Home Care Settings
  • Hospitals & Clinics
  • Research & Academic Laboratories

This research report categorizes the Diabetes Care Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Diabetes Care Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Arkray, Inc.
  • B. Braun SE
  • Becton, Dickinson, and Company
  • Bionime Corporation
  • DexCom, Inc.
  • Eli Lilly and Company
  • F.Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetes Care Devices Market, by Device Type
8.1. Introduction
8.2. Blood Glucose Monitoring Devices
8.2.1. Continuous Glucose Monitoring (CGM) Devices
8.2.1.1. Receiver
8.2.1.2. Sensors
8.2.1.3. Transmitters
8.2.2. Self-Monitoring Of Blood Glucose (SMBG) Devices
8.2.2.1. Blood Glucose Meters
8.2.2.2. Lancets
8.2.2.3. Test Strips
8.3. Insulin Delivery Devices
8.3.1. Insulin Pens
8.3.1.1. Disposable Insulin Pens
8.3.1.2. Reusable Insulin Pens
8.3.2. Insulin Pumps
8.3.2.1. Patch Pumps
8.3.2.2. Traditional Insulin Pumps
8.3.3. Insulin Syringes
9. Diabetes Care Devices Market, by End User
9.1. Introduction
9.2. Diagnostic Centers
9.3. Home Care Settings
9.4. Hospitals & Clinics
9.5. Research & Academic Laboratories
10. Americas Diabetes Care Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Diabetes Care Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Diabetes Care Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Analysis
13.3.1. Abbott Laboratories
13.3.2. Acon Laboratories, Inc.
13.3.3. AgaMatrix, Inc.
13.3.4. Arkray, Inc.
13.3.5. B. Braun SE
13.3.6. Becton, Dickinson, and Company
13.3.7. Bionime Corporation
13.3.8. DexCom, Inc.
13.3.9. Eli Lilly and Company
13.3.10. F.Hoffmann-La Roche AG
13.3.11. Johnson & Johnson Services, Inc.
13.3.12. Medtronic PLC
13.3.13. Nova Biomedical, Inc.
13.3.14. Novo Nordisk A/S
13.3.15. Sanofi S.A.
14. ResearchAI
15. ResearchStatistics
16. ResearchContacts
17. ResearchArticles
18. Appendix
List of Figures
FIGURE 1. DIABETES CARE DEVICES MARKET MULTI-CURRENCY
FIGURE 2. DIABETES CARE DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. DIABETES CARE DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RECEIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISPOSABLE INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TRADITIONAL INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 62. CANADA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 63. CANADA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 64. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 65. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 66. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 67. CANADA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 70. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 71. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 72. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 73. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. CHINA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. CHINA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 104. CHINA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 105. CHINA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 106. CHINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 107. CHINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 108. CHINA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 109. CHINA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. INDIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 112. INDIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 113. INDIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 114. INDIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 115. INDIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 116. INDIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 117. INDIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 127. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 128. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 129. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 130. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 131. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 132. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 168. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 175. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 176. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 177. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 178. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 179. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 180. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 181. THAILAND DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 183. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 184. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 199. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 201. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 202. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 203. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 204. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 208. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 210. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 211. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 212. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 213. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 216. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 217. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 218. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 219. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 220. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 225. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 226. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 227. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 232. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 233. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 234. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 235. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 236. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. ITALY DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 248. ITALY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. ITALY DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 250. ITALY DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 251. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 252. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 253. ITALY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 254. ITALY DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 273. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 274. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 275. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 276. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 278. NORWAY DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. POLAND DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 280. POLAND DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 281. POLAND DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 282. POLAND DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 283. POLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 284. POLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 285. POLAND DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 286. POLAND DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. QATAR DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 288. QATAR DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 289. QATAR DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 290. QATAR DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 291. QATAR DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 292. QATAR DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 293. QATAR DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 294. QATAR DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY BLOOD GLUCOSE MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING (CGM) DEVICES, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA DIABETES CARE DEVICES MARKET SIZE, BY SELF-MONITORING OF BLOO

Companies Mentioned

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Arkray, Inc.
  • B. Braun SE
  • Becton, Dickinson, and Company
  • Bionime Corporation
  • DexCom, Inc.
  • Eli Lilly and Company
  • F.Hoffmann-La Roche AG
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Nova Biomedical, Inc.
  • Novo Nordisk A/S
  • Sanofi S.A.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Diabetes Care Devices Market Report by Type, Distribution Channel, End User, and Region 2024-2032 - Product Image

Diabetes Care Devices Market Report by Type, Distribution Channel, End User, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
Diabetes Care Devices - Global Strategic Business Report - Product Image

Diabetes Care Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Diabetes Care Devices Market by Product Type, Technology, Distribution Channel, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Diabetes Care Devices Market by Product Type, Technology, Distribution Channel, and End-User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 235 Pages
  • Global
From
Diabetes Care Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Diabetes Care Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 157 Pages
  • Global
From
Diabetes Care Devices Market Report 2025 - Product Image

Diabetes Care Devices Market Report 2025

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.